Rogers Rebecca, Luk Lincoln, Ross Rachel, Cowling Laura, Wall Benjamin, Lawson-Smith Matthew
FHHS DOHS, FHHS DOOS, Notre Dame University, University of Western Australia, Fremantle, Western Australia.
J Hand Surg Glob Online. 2024 Apr 15;6(3):344-348. doi: 10.1016/j.jhsg.2024.02.002. eCollection 2024 May.
The primary purpose of our study was to investigate hamate fractures at a single tertiary hand surgery unit in Western Australia, particularly comparing operative and nonsurgical outcomes.
Patients with hamate and/or hamate plus fifth carpometacarpal injury at our hand unit between 2019 and 2022 were identified. All patients had Quick Disability of the Arm, Shoulder and Hand (DASH) patient-reported outcome measures recorded post treatment. Patients managed operatively and nonsurgically had a period of splinting with plaster of Paris and/or thermoplastic splint for a minimum of 2 weeks. All patients underwent hand therapy.
Forty-eight patients with hamate and/or hamate plus fifth carpometacarpal injury were included in this study. Thirteen patients had Milch type 1 fractures, and 35 had Milch type 2 fractures. Six Milch type 1 fractures were managed operatively, and seven were managed nonsurgically. The average DASH score for the operative group was 0.38. The average DASH score for the nonsurgical group was 0.65. Sixteen Milch type 2 fractures were managed operatively, and 19 were managed nonsurgically. The average DASH score for the operative group was 1.3. The average DASH score for the nonsurgical group was 3.5.
For Milch type 2 fractures, patient-reported outcome measures were better for the operative group compared with the nonsurgical group.
TYPE OF STUDY/LEVEL OF EVIDENCE: Therapeutic IV.
我们研究的主要目的是调查西澳大利亚一家三级手部手术单位的钩骨骨折情况,特别是比较手术和非手术治疗的结果。
确定2019年至2022年期间在我们手部科室患有钩骨和/或钩骨加第五掌骨骨折的患者。所有患者在治疗后均记录了患者报告的手臂、肩部和手部快速残疾程度(DASH)指标。接受手术和非手术治疗的患者均用巴黎石膏和/或热塑性夹板固定至少2周。所有患者均接受手部治疗。
本研究纳入了48例患有钩骨和/或钩骨加第五掌骨骨折的患者。13例为米尔希1型骨折,35例为米尔希2型骨折。6例米尔希1型骨折接受手术治疗,7例接受非手术治疗。手术组的平均DASH评分为0.38。非手术组的平均DASH评分为0.65。16例米尔希2型骨折接受手术治疗,19例接受非手术治疗。手术组的平均DASH评分为1.3。非手术组的平均DASH评分为3.5。
对于米尔希2型骨折,与非手术组相比,手术组患者报告的结果指标更好。
研究类型/证据水平:治疗性IV级。